April 2, 2020 ARCH News from ARCH Venture Partners | Share ARCH Venture Partners Announces $1.46 Billion Raised in Two New Funds to Invest in Transformative Biotechnology Companies
March 31, 2020 ARCH News from ARCH Venture Partners | Share Co-Founder and Managing Director Robert Nelsen Discusses COVID-19 and What’s Next with STAT’s Adam Feuerstein
March 30, 2020 Portfolio News from ARCH Venture Partners | Share VBI Vaccines Developing Pan-Coronavirus Vaccine Candidate
March 27, 2020 Portfolio News from ARCH Venture Partners | Share deCODE Genetics Continues Prolific COVID-19 Testing
March 25, 2020 Portfolio News from ARCH Venture Partners | Share Vir Biotechnology to Test COVID-19 Antibody
March 20, 2020 Portfolio News from ARCH Venture Partners | Share Bellerophon Therapeutics Gets FDA Emergency Approval for INOpulse to Treat COVID-19
March 4, 2020 Portfolio News from ARCH Venture Partners | Share Alnylam Pharmaceuticals in COVID-19 Partnership with Vir
March 3, 2020 Portfolio News from ARCH Venture Partners | Share Twist Bioscience Developing COVID-19 Research Tools
February 7, 2020 Portfolio News from ARCH Venture Partners | Share Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered
February 6, 2020 Portfolio News from ARCH Venture Partners | Share Sonoma Bio debuts with $40M to push Treg treatments for autoimmune and neurodegenerative diseases
January 13, 2020 Portfolio News from ARCH Venture Partners | Share A ‘radical proposition’: A health care veteran tries to upend the system and bring drug prices down
